Armed With An FDA-Cleared IND, TLS Sets Out To Democratize Clinical Trials

04 Feb 2013

• By Michael Goodman

Transparency Life Sciences applies crowdsourcing to the design of clinical protocols with the aim of lowering costs and improving outcomes for clinical trials. The company won FDA clearance for its first IND based on a protocol that resulted from its process and is securing its first financing.

Transparency Life Sciences LLC (TLS) is trying to disrupt the way drugs are developed.

Founded in 2010, TLS is the first company to apply the principles of crowdsourcing to the development of clinical trial...